Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Aug 24;161(4):381–385.

Going the distance: the influence of practice location on the Ontario Maternal Serum Screening Program

J A Permaul-Woods 1, J C Carroll 1, A J Reid 1, C A Woodward 1, G Ryan 1, S Domb 1, S Arbitman 1, B Fallis 1, J Kilthei 1
PMCID: PMC1230538  PMID: 10478161

Abstract

BACKGROUND: The Ontario Maternal Serum Screening (MSS) Program was introduced by the Ontario Ministry of Health as a province-wide pilot project in 1993. The objective of this study was to determine the influence of practice location on Ontario health care providers' use of and opinions regarding MSS, access to follow-up services and recommendations about the program. METHODS: A questionnaire was mailed to a random sample of 2000 family physicians, all 565 obstetricians and all 62 registered midwives in Ontario between November 1994 and March 1995. RESULTS: Among providers who were eligible (those providing antenatal care or attending births) the response rates were 91.4% (778/851), 76.0% (273/359) and 78.0% (46/59) respectively. Fewer respondents in the Northwest region (71.4%) and in rural areas (81.9%) stated that they routinely offer MSS to all pregnant women in their practices compared with respondents in other regions (84.4%-91.5%) and urban centres (90.1%). Fewer respondents in the northern regions (Northeast 49.2%, Northwest 25.0%) than in the Central East region (includes Toronto) (76.6%) felt that follow-up services were readily available. Respondents in the northern regions had less favourable opinions of MSS than those in the other regions in terms of its complexity, cost, the time involved in counselling and the high false-positive rate. More respondents in the Central East region (64.6%) and in urban centres (52.9%) recommended not changing the MSS program than did those in the Northwest (7.1%) and rural areas (39.8%). After provider characteristics were controlled for in a logistic regression analysis, practice location was not the most important factor. Instead, the model showed that respondents who cared for 50 or more pregnant women in the previous year were more likely to offer MSS routinely (OR 2.00, 95% CI 1.21-3.27) and that those who felt that patient characteristics affect the offering of MSS (OR 0.42, 95% CI 0.26-0.67) or that follow-up services were not readily available (OR 0.33, 95% CI 0.20-0.55) were less likely to offer it. INTERPRETATION: Health care providers in northern and rural Ontario were less likely to offer MSS routinely than those in other regions and were more likely to recommend changing or eliminating the program. Providers' concerns about the social and cultural sensitivity of MSS and the availability of follow-up services affected use.

Full Text

The Full Text of this article is available as a PDF (203.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borgiel A. E., Williams J. I., Bass M. J., Dunn E. V., Evensen M. K., Lamont C. T., MacDonald P. J., McCoy J. M., Spasoff R. A. Quality of care in family practice: does residency training make a difference? CMAJ. 1989 May 1;140(9):1035–1043. [PMC free article] [PubMed] [Google Scholar]
  2. Carroll J. C., Reid A. J., Woodward C. A., Permaul-Woods J. A., Domb S., Ryan G., Arbitman S., Fallis B., Kilthei J. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. CMAJ. 1997 Mar 15;156(6):775–784. [PMC free article] [PubMed] [Google Scholar]
  3. Cheng E. Y., Luthy D. A., Zebelman A. M., Williams M. A., Lieppman R. E., Hickok D. E. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol. 1993 Jan;81(1):72–77. [PubMed] [Google Scholar]
  4. Dick P. T. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. CMAJ. 1996 Feb 15;154(4):465–479. [PMC free article] [PubMed] [Google Scholar]
  5. Dillon M., Lam T., Beardy N., Gordon J., Dooley J., Harris S. Maternal serum screening in the Sioux Lookout Zone. Complicated test for an unspecified need. Can Fam Physician. 1994 Oct;40:1766–1771. [PMC free article] [PubMed] [Google Scholar]
  6. Gekas J., Gondry J., Mazur S., Cesbron P., Thepot F. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn. 1999 Jan;19(1):1–7. doi: 10.1002/(sici)1097-0223(199901)19:1<1::aid-pd456>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  7. Goodburn S. F., Yates J. R., Raggatt P. R., Carr C., Ferguson-Smith M. E., Kershaw A. J., Milton P. J., Ferguson-Smith M. A. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Prenat Diagn. 1994 May;14(5):391–402. doi: 10.1002/pd.1970140509. [DOI] [PubMed] [Google Scholar]
  8. Haddow J. E., Palomaki G. E., Knight G. J., Williams J., Pulkkinen A., Canick J. A., Saller D. N., Jr, Bowers G. B. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med. 1992 Aug 27;327(9):588–593. doi: 10.1056/NEJM199208273270902. [DOI] [PubMed] [Google Scholar]
  9. Maheux B., Beaudoin C., Jacques A., Lambert J., Lévesque A. Effects of residency training in family medicine v. internship training on professional attitudes and practice patterns. CMAJ. 1992 Mar 15;146(6):901–907. [PMC free article] [PubMed] [Google Scholar]
  10. Marteau T. M., Slack J., Kidd J., Shaw R. W. Presenting a routine screening test in antenatal care: practice observed. Public Health. 1992 Mar;106(2):131–141. doi: 10.1016/s0033-3506(05)80390-7. [DOI] [PubMed] [Google Scholar]
  11. Palomaki G. E., Knight G. J., Haddow J. E., Canick J. A., Saller D. N., Jr, Panizza D. S. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn. 1992 Nov;12(11):925–930. doi: 10.1002/pd.1970121112. [DOI] [PubMed] [Google Scholar]
  12. Piggott M., Wilkinson P., Bennett J. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group. J Med Screen. 1994 Jan;1(1):45–49. doi: 10.1177/096914139400100109. [DOI] [PubMed] [Google Scholar]
  13. Tudiver F., Permaul-Woods J. A. Physicians' perceptions of and approaches to woman abuse. Does certification in family medicine make a difference? Can Fam Physician. 1996 Aug;42:1475–1480. [PMC free article] [PubMed] [Google Scholar]
  14. Wald N. J., Cuckle H., Brock J. H., Peto R., Polani P. E., Woodford F. P. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet. 1977 Jun 25;1(8026):1323–1332. [PubMed] [Google Scholar]
  15. Wald N. J., Kennard A., Densem J. W., Cuckle H. S., Chard T., Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ. 1992 Aug 15;305(6850):391–394. doi: 10.1136/bmj.305.6850.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Woodward C. A., Cohen M., Ferrier B. M., Goldsmith C. H., Keane D. Correlates of certification in family medicine in the billing patterns of Ontario general practitioners. CMAJ. 1989 Nov 1;141(9):897–904. [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES